APA (7th ed.) Citation

de Latour, R. P., Szer, J., Weitz, I., Röth, A., Höchsmann, B., Panse, J., . . . Hillmen, P. (2021). 3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT. Experimental hematology, 100, S97. https://doi.org/10.1016/j.exphem.2021.12.330

Chicago Style (17th ed.) Citation

de Latour, Régis Peffault, et al. "3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT." Experimental Hematology 100 (2021): S97. https://doi.org/10.1016/j.exphem.2021.12.330.

MLA (9th ed.) Citation

de Latour, Régis Peffault, et al. "3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT." Experimental Hematology, vol. 100, 2021, p. S97, https://doi.org/10.1016/j.exphem.2021.12.330.